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Summary
Theeukaryoticnonsense-mediatedmRNAdecay (NMD)
pathway degrades mRNAs carrying premature stop
codons (PTC). In humans, NMD depends on the RNA-
and DNA-dependent 50-30 helicase UPF1 and six other
gene products referred to as SMG1, UPF2, UPF3,
EST1A/SMG6, EST1B/SMG5, and EST1C/SMG7. The
NMD machinery is also thought to coordinate mRNA
nuclear export and translation and to regulate the
levels of several physiologic transcripts [1–7]. Further-
more, in a process named SMD, UPF1 promotes degra-
dation of mRNAs that are bound by Staufen 1 [8].
Intriguingly, SMG1 and EST1A/SMG6 function also in
DNA repair and telomere maintenance, respectively
[9–11]. Here, we show that UPF1 is also required for
genome stability. shRNA-mediated depletion of UPF1
causes humancells to arrest early in Sphase, inducing
an ATR-dependent DNA-damage response. A fraction
of hyperphosphorylated UPF1 associates with chro-
matin of unperturbed cells, and chromatin association
increases inSphase andupong irradiation. ATRphos-
phorylates UPF1 both in vitro and in vivo, and shRNA-
mediated downregulation of ATR diminished the asso-
ciation of UPF1 with chromatin, although it did not
affect NMD. Physical interaction of UPF1 with DNA
polymerase d suggests a role for human UPF1 in DNA
synthesis during replication or repair.
Results and Discussion
To study the physiological role of human UPF1, we
transfected HeLa cells with two shRNA vectors (shRNAI
and shRNAII) targeting different 19 nucleotide regions
of the UPF1 mRNA. Western-blot analysis shows that
both shRNAs efficiently reduce UPF1 levels to 10%–20%
5 days after transfection (Figure 1A). As expected,
shRNAI- and shRNAII-mediated depletion of UPF1 leads
to stabilization of the PTC-containing reporter mRNA
b-globinNS39 (Figure S1 in the Supplemental Data avail-
able online) and of an endogenous PTC-containing
ABCC4 splice variant (ABCC4SV2, see below) known to
be constantly degraded by NMD [12]. Four to seven
days after transfection with shRNAI and shRNAII, HeLa
cells stopped proliferating and showed severe morpho-
*Correspondence: joachim.lingner@isrec.chlogical changes, with cytoplasm and nuclei enlarging
3–5-fold (Figure S2). The capacity to form colonies was
reduced 20–50-fold (Figure 1B). This was not attributable
to apoptosis because cells did not stain positive for
the apoptotic marker Annexin V, nor did they exhibit
Caspase activation (datanot shown). Similar results were
obtained with the renal epithelial cell line 293T, the fibro-
sarcoma-derived cell line HT1080, and the osteosar-
coma-derived U2OS cells (data not shown).
As determined by flow cytometry, cells depleted for
UPF1 accumulate with a DNA content slightly higher
than 2n (M1 region in Figure S2), potentially correspond-
ing to early S phase. Consistently, a 1:1 mixture of cells
transfected with empty vector and with shRNAII pro-
duced a peak in between the G1 peak of the empty vec-
tor and the M1 peak of the UPF1-shRNA-treated cells
(Figure S2). UPF1 depletion also induces the appear-
ance of cells with DNA content higher than 4n. The >4n
cells may correspond to the cells with enlarged nuclei
observed by microscopic inspection (Figure S2). Normal
cell-cycle distribution was restored when shRNAII vec-
tor was cotransfected with a plasmid driving the expres-
sion of a transgenic Flag-UPF1 protein (F-UPF12054) from
a cDNA with the shRNAII target site mutated (Figure S3).
This confirms that the described cell-cycle defect was
due to depletion of UPF1 and was not caused by off-
target effects. Importantly, cells shRNA-depleted for the
NMD factor UPF2 [13] progressed normally through the
cell cycle (Figure S2), whereas NMD was impaired (Fig-
ure S1). This suggests that the defective cell-cycle pro-
gression of UPF1-depleted cells is not due to loss of
general NMD.
To verify the early S phase arrest in UPF1-depleted
cells, we measured DNA synthesis by pulse labeling
with bromodeoxyuridine (BrdU) for 15 hr between days
3 and 4 after transfection. In the empty-vector sample, a
large fraction (80%) of the cells was BrdU positive and
distributed in all phases of the cell cycle (Figure 1C). In
the shRNA samples, a lower number of cells was BrdU
positive (14% for shRNAI and 55% for shRNAII), con-
firming that UPF1 depletion perturbs cell-cycle pro-
gression. Furthermore, a large fraction (71%) of BrdU-
positive cells had a similar DNA content (referred to as
R1 in Figure 1C). We also used an anti-PCNA monoclo-
nal antibody to stain shRNA-treated cells after methanol
fixation in order to specifically detect PCNA associated
with replication forks [14, 15]. The fraction of PCNA-
positive cells increased upon UPF1 depletion, and the
intranuclear distribution pattern of PCNA foci indicated
that the vast majority of these cells were in early S phase
(Figure 1D). We conclude that UPF1-depleted cells can
initiate but not complete DNA replication.
Inhibition of DNA replication-fork progression triggers
a DNA-damage response [16–18]. Therefore, we stained
UPF1-depleted cells with antibodies against phosphor-
ylated histone H2AX (g-H2AX), a sensitive marker for
damaged DNA. The fraction of g-H2AX-positive cells in-
creased significantly in UPF1-shRNA-treated cells from
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434Figure 1. shRNA Depletion of UPF1 Induces
S Phase Arrest in HeLa Cells
(A) HeLa cells were transfected with empty-
vector control (e.v.) and with anti-UPF1 shRNA
vectors I and II. After 1, 3, and 5 days, total
protein was extracted, and expression of
UPF1 was assessed by western blotting.
a-Tubulin was used as loading control.
(B) Colony-forming assay of HeLa cells de-
pleted for UPF1. Cloning efficiency of the
shRNA-treated cells is expressed relative to
the empty-vector control from three indepen-
dent experiments.
(C) BrdU incorporation in HeLa cells trans-
fected with shRNAI and shRNAII and with
empty-vector control. Pulse labeling was per-
formed for 15 hr between days 3 and 4 after
transfection. BrdU incorporation (y axis) was
determined by using FITC-labeled anti-BrdU
antibody, and DNA content was measured
with 7-aminoactinomycin D (7-ADD; x axis).
BrdU-negative cells are shown in red, and
BrdU-positive cells are shown in green. Per-
centages indicate the total fraction of BrdU-
positive cells (BrdU+) and the fraction of BrdU
positive cells that accumulate in the R1 region
(light green).
(D) PCNA staining of HeLa cells fixed with
methanol 4 days after transfection with
shRNAI and shRNAII and with empty-vector
control. The PCNA signal is shown in green;
DAPI-stained DNA is shown in blue. The total
fraction of PCNA-positive cells and the frac-
tion of PCNA positive cells showing a PCNA
pattern characteristic of early (e) and middle-
late (m-l) S phase are indicated. One hundred
cells were scored for each sample. The results
presented in (C) and (D) are from independent
representative experiments.approximately 22% to 58% (Figures 2A and 2B). Further-
more, the overall intensity of the individual g-H2AX foci
observed in empty-vector-transfected cells was consid-
erably lower than that observed in shRNA-treated cells.
Expression of shRNA-resistant F-UPF12054 rescued the
cells from accumulating g-H2AX (Figure S3), proving that
the DNA-damage response was an authentic outcome
of UPF1 depletion. As for the cell-cycle defect, g-H2AX
accumulation was not observed in U2OS cells depleted
for UPF2 (Figure 2B), supporting an NMD-independent
role for UPF1 in S phase progression and genome stabil-
ity. However, this does not rule out involvement of the
UPF1-dependent (andUPF2-independent)SMD[8].Con-
sistent with the accumulation of DNA damage, meta-
phases that could be prepared from UPF1-depleted cells
relieved from cell-cycle arrest upon treatment with the
phosphoinositide-3-kinase-related kinase (PIKK) inhibi-
tor caffeine showed a 3-fold increase in the total number
of chromatid breaks and a 8–9-fold increase in the total
number of chromosome breaks (Table 1 and Figure S4).
Accumulation of acentric fragments, dicentrics, and
radial chromosomes was also observed. These observa-
tions were further substantiated by using a single-cell
gel-electrophoresis assay (‘‘comet assay’’), in which
nuclei release broken DNA fragments upon migration
in an electric field (Figure S4). We speculate that the
observed chromosomal aberrations arose at the sites
where the replication forks arrested because of UPF1
depletion.Phosphorylation of H2AX is mediated by the PIKKs
ATM and ATR, which become activated upon DNA dam-
age [17, 18]. Immunostaining and western-blot analysis
of shRNA-treated U2OS and HeLa cells with antibodies
against activated ATM (phosphorylated at Ser 1981)
showed no significant activation of this kinase (Figure 2C
and data not shown). Consistently, western-blot exper-
iments also failed to detect phosphorylation of the ATM
substrate CHK2 (data not shown). To test for activation
of ATR, we used U2OS-derived GW33 cells stably ex-
pressing FLAG-epitope-tagged ATR [19]. Flag-tagged
ATR protein formed foci in more than 60% of the cells
treated with shRNA against UPF1, whereas fewer than
10% of the empty-vector-treated cells showed ATR
foci (Figure 2C). We then performed double-transfection
experiments with shRNAs against UPF1 and ATM or ATR
[20, 21] (validated in Figure S1). In cells depleted for both
ATM and UPF1, g-H2AX was induced to a similar extent
as in cells depleted for UPF1 only. In contrast, when cells
were simultaneously depleted for both ATR and UPF1,
g-H2AX levels were substantially reduced (Figure 2D).
Thus the DNA-damage response induced by UPF1 de-
pletion is largely mediated by ATR. This is consistent
with the observation that UPF1-depleted cells arrest in
S phase, because ATR is thought to be the PIKK primar-
ily involved in regulating the cellular response to replica-
tion block [17, 18].
To test for a direct role of UPF1 in DNA metabolism,
we prepared soluble and chromatin-associated protein
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435Figure 2. shRNA Depletion of UPF1 Induces an ATR-Dependent DNA-Damage Response
(A) HeLa cells were transfected with shRNAI and with empty-vector control and stained with mouse monoclonal antibodies against g-H2AX
(white signal). DAPI-stained DNA is shown in gray. The graph illustrates the fraction of cells with at least four g-H2AX foci (positive cells) detected
in empty-vector control and in shRNAI-treated cells 3, 4, and 5 days after transfection. Data are from one representative experiment where
50 cells were scored for each time point.
(B) U2OS cells were transfected with empty vectors, UPF1 shRNAI, and two independent shRNAs against UPF2. UPF1, UPF2, and g-H2AX pro-
tein levels were assessed by western blotting 4 days after transfection. a-Tubulin was used as loading control.
(C) U2OS and GW33 cells were transfected with shRNAI and with empty-vector control. Three days after transfection, cells were stained with
anti-phospho-ATM Ser1981 (U2OS cells) and with anti-Flag monoclonal antibodies (GW33). As positive controls, cells were g-irradiated with
10 Gy or UV-irradiated with 100 J/m2 and processed 2 hr after treatment. ATM and Flag-ATR foci are shown in white. The graph shows quanti-
fication of cells containing at least four phospho-ATM or 4 Flag-ATR foci (positive cells). Mean percentage values were obtained from two in-
dependent experiments and expressed as a fraction of the total number of cells (50) analyzed in each experiment. Error bars indicate the
mean 6 standard deviation for two experiments.
(D) HeLa cells were simultaneously transfected with shRNA against UPF1 (shRNAI) and ATM or ATR kinases. Four days after transfection, total-
cell extracts were prepared and the levels of UPF1 and g-H2AX were determined by western blotting. CENPA was used as loading control.fractions from HeLa cells [22]. The majority of UPF1 pro-
tein was detected in the soluble fraction. Nevertheless,
a significant fraction of UPF1 (about 4%) was chromatin
bound (Figure 3A and Figure S5). Supporting these
observations, chromatin-immunoprecipitation experi-
mentsof formaldehydecross-linkedcells, followedbyde-
tection of Alu-element-containing genomic DNA, showed
association of UPF1 with about 2% of input DNA (Fig-
ure S5). Strikingly, a 4-fold increase of the amount of
chromatin-associated UPF1 was detected in cells en-
riched in S phase upon the release from a hydroxyurea
block (Figure S5). As expected, the nuclear marker
nucleolin and the cytoplasmic marker a-tubulin weredetected only in the soluble fraction. In contrast and con-
sistent with published results [22], PCNA was present in
the insoluble fractions from nonsynchronized cells, and
its association strongly increased in S phase as ob-
served for UPF1 (Figure 3 and Figure S5). It is possible
that at least a part of the UPF1 association with chroma-
tin upon hydroxyurea treatment is due to the DNA dam-
age derived from nucleotide depletion. Therefore, we
also released cells from a nocodazole-induced meta-
phase block and followed the kinetics of the UPF1 chro-
matin association (Figure 3A). Cell-cycle progression
was trackedbyFACSanalysis (datanotshown). Whereas
minor fluctuations of UPF1 were observed in the solubleTable 1. Chromosomal Aberrations in HeLa Cells Depleted for UPF1
Analyzed
Metaphases
# Chromosomes/
Metaphase
Chromatid
Breaks (tot #)
Chromosome
Breaks (tot #)
Dicentrics
(tot #)
# MetaphasesR 5
Chromatid Breaks
# MetaphasesR 1
Chromosome Breaks
Empty vector 25 73.8 6 5.4 79 2 3 6 2
shRNAI 24 69.3 6 15.1 221 16 10 21 9
shRNAII 25 71.8 6 7.6 233 18 9 19 12
Results are from one representative experiment.
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436Figure 3. UPF1 Associates with the Chromatin of Untreated and g-Irradiated HeLa Cells through ATR-Mediated Phosphorylation
(A) HeLa cells were blocked in mitosis with Nocodazole for 12 hr and then released from the block. Soluble (SOL) and DNA-bound (DN) protein
extracts were prepared every 2 hr over a time course of 18 hr, and UPF1, PCNA, and a-Tubulin levels were assayed by western blotting. Numbers
at the bottom indicates the levels of soluble and DNA-bound UPF1 expressed relative to UPF1 signal in the asynchronous sample (indicated by a)
after normalization with the signal of a-Tubulin and an unspecific cross-reacting band (asterisk) detected with an unrelated rabbit serum. Differ-
ent phases of the cell cycle are indicated.
([B], upper panels) HeLa cells were g-irradiated with 0, 1, 5, and 20 Gy, and soluble and DNA-bound protein fractions as well as whole-cell ex-
tracts (WC) were prepared 2 hr after irradiation and assayed for UPF1, a-Tubulin, and g-H2AX.
([B], lower panels) HeLa cells were g-irradiated with 10 Gy, and soluble and DNA-bound protein fractions as well as total-cell extracts were pre-
pared 1, 2, and 8 hr after irradiation and assayed for UPF1, Ku86, a-Tubulin, and g-H2AX. Numbers at the bottom indicate the levels of soluble and
DNA-bound UPF1, normalized for total protein content with the a-Tubulin signal and expressed relative to the UPF1 signal in the untreated (un)
sample.
(C) HeLa cells were transfected with shRNA vectors against ATM, ATR, or SMG1 kinases. Four days after transfection, cells were irradiated with
0 or 10 Gy, and UPF1, SMG1, ATR, and ATM were detected by western blotting. The a-Tubulin signal and an unspecific band (asterisk) detected
with an unrelated rabbit serum were used as normalization controls for protein loading in soluble and DNase fractions, respectively. Numbers are
as in (B).
(D) HeLa b-globinWT (two upper panels) and HeLa b-globinNS39 (other panels) cells were transfected with shRNAs against UPF1 (shRNAII) and
ATR. Four days after transfection, cells were g-irradiated with 0 and 10 Gy. Two hours later, total RNA, soluble proteins, and chromatin-bound
proteins were prepared. Northern-blot analysis was performed to detect b-globinWT, b-globin NS39, and UPF1 mRNAs; RT-PCR analysis was used
to detect ABCC4 wild-type (wt) and splice variant 2 (SV2) containing a PTC; western-blot analysis was performed to detect UPF1 and ATR. Actin,
ARF3, a-Tubulin, and an unspecific band (asterisk) from an unrelated rabbit serum were used as loading controls in the different experiments.
(E) Soluble and DNase fractions were prepared from HeLa cells, and endogenous UPF1 was immunoprecipitated by using goat polyclonal an-
tibodies. Parallel IP experiments using goat polyclonal antibodies against actin were performed to control for IP specificity. Immunoprecipitated
material was blotted to nitrocellulose membranes and probed with anti-phospho-S/T-Q and anti-UPF1 antibodies (UPF1 IP is shown in dupli-
cate). Numbers indicate the mean ratio of anti-phospho-S/T-Q signal relative to the anti-UPF1 signal for the same sample. Values are normalized
to the signal in the soluble samples.
(F) Immunopurified Flag-tagged ATR and ATR kinase dead (ATRKD) were incubated with immunopurified Flag-tagged UPF1 (F-UPF1). Control
experiments were performed with empty-vector control (F-e.v.). Kinase reactions were performed in presence of g-[32P]ATP. Proteins were
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437fraction, its chromatin association was strongly depen-
dent on the cell-cycle stage. The levels of chromatin-
bound UPF1 were very low in mitosis and early G1,
started to increase in mid-G1, and reached highest
values in S phase (about 6–7-fold increase compared to
the asynchronous population). Upon S phase exit, chro-
matin association of UPF1 started again to diminish. In
this experiment, chromatin association of PCNA showed
similar cell-cycle dependence as UPF1.
We then set out to test whether UPF1 was responding
to DNA damage. HeLa cells were g-irradiated, and UPF1
association with chromatin was assayed 2 hr after irradi-
ation. Soluble UPF1 levels increased 2–3.5-fold upon dif-
ferent doses of g irradiation (Figure 3B), correlating with
an approximately 2-fold increase of UPF1 mRNA (Fig-
ure 3D). Strikingly, a more pronounced g-ray dose-
dependent increase of UPF1 (up to 9.5-fold increase
with 20 Gy) was observed in the chromatin-bound frac-
tions (Figure 3B). Consistently, chromatin-immunopre-
cipitation experiments showed a 12-fold increase in
the amount of DNA associated to UPF1 when cells
were irradiated with 20 Gy (Figure S5). Kinetic analysis
demonstrated maximal accumulation of UPF1 on chro-
matin 2 hr after irradiation. Interestingly, the DNA-repair
factor Ku86 accumulated on chromatin with kinetics
similar to UPF1, whereas g-H2AX peaked after 1 hr
(Figure 3B).
To investigate the role of different PIKKs in promoting
association of UPF1 with chromatin, we transfected
HeLa cells with shRNAs against ATM, ATR, and SMG1
kinases (see Figure S1). Four days after transfection,
we g-irradiated the cells with 10 Gy and prepared solu-
ble and chromatin-bound protein fractions. ShRNA-me-
diated depletion of ATM did not affect the g-irradiation-
induced chromatin association of UPF1 (Figure 3C). On
the contrary, depletion of SMG1 induced 3-fold-higher
levels of soluble and chromatin-bound UPF1 protein in
both untreated and g-irradiated samples (Figure 3C).
Given that SMG1-shRNA induces DNA damage ([9] and
our unpublished results), we speculate that the higher
amounts of chromatin-bound UPF1 may be a cellular re-
sponse to DNA damage. When ATR was depleted, the
levels of chromatin-bound UPF1 were reduced to 60%
as compared to the empty-vector-treated cells, demon-
strating a critical role of this kinase for loading UPF1 onto
chromatin during normal cell-cycle progression. In addi-
tion, UPF1 did not accumulate on chromatin in response
to g irradiation in ATR-depleted cells (Figures 3C and
3D). Importantly, although the achieved degree of ATR
depletion impaired the ability of UPF1 to associate with
chromatin, it did not affect NMD as measured with the
b-GlobinNS39 reporter and ABCC4SV2 (Figure 3D). Be-
cause b-globinNS39 NMD has been reported to occur
predominantly in nuclear-associated fractions of the
cells [23], we also analyzed RNA prepared from nuclear
fractions and obtained similar results (data not shown).Thus, the ATR-dependent association of UPF1 with
chromatin has no apparent function in NMD.
Human UPF1 is a phosphoprotein containing 28 S/T-Q
consensus sites for PIKKs, and at least one serine near
the C terminus (S1096) is a known target of the SMG1
kinase during NMD [24]. To test whether chromatin
association of UPF1 correlates with PIKK-mediated
phosphorylation, endogenous UPF1 was immunopre-
cipitated from soluble and DNase fractions from HeLa
cells and the relative proportion of phospho-UPF1 in
each fraction was determined in western blots with
anti-phospho-S/T-Q antibodies. The relative amount of
phospho-UPF1 was 2.5-fold higher in chromatin bound
versus unbound fraction (Figure 3E). Enrichment of
phospho-UPF1 on chromatin was also seen when we
overexpressed a Flag-tagged version of UPF1 and per-
formed immunoprecipitation experiments with anti-
Flag antibodies (data not shown). These results raise
the possibility that the observed ATR-dependent chro-
matin loading of UPF1 is directly regulated by ATR-me-
diated phosphorylation. Therefore, we performed an in
vitro kinase assay by incubating Flag-tagged UPF1 pro-
tein with ATR or ATR kinase-dead (ATRKD) proteins in the
presence of g[32P] ATP. Reactions were analyzed by
SDS-PAGE and autoradiography. UPF1 was phosphory-
lated in the reaction containing active ATR, whereas
barely any phospho-UPF1 was detected in the reaction
samples containing ATRKD (Figure 3F). The residual
phosphorylation observed in the ATRKD samples may
be due to traces of endogenous active ATR, coimmuno-
precipitated with Flag-tagged ATRKD (Figure 3F). Con-
sistently, we found that shRNA-mediated depletion of
ATR substantially reduces the levels of phosphorylated
UPF1 in the cell (Figure 3G). Thus, ATR is a UPF1 kinase
in vitro and is required for UPF1 phosphorylation in vivo.
It has been reported thatg irradiation induces SMG1- and
ATM-dependent phosphorylation of UPF1 [9]. However,
shRNA-mediated depletion of SMG1 and ATM did not
interfere with the chromatin association of UPF1
(Figure 3C), even though SMG1 and ATM functions
were partially lost (see Figure S1). We conclude that
ATR-mediated phosphorylation regulates UPF1 loading
onto chromatin during normal cell-cycle progression.
Furthermore, g irradiation triggers not only SMG1- and
ATM-dependent phosphorylation of UPF1, but also
ATR-dependent phosphorylation events that lead to
UPF1 accumulation onto chromatin. The timing of UPF1
loading onto chromatin upon g irradiation (Figure 3B,
see above) is consistent with ATR regulating the late
phase (2–9 hr after irradiation) of the response to IR [25].
What is the function of chromatin-bound UPF1? Hu-
man UPF1 may sustain genome stability as a component
of DNA replication and/or repair machineries. In support
of this hypothesis, it has been reported that bovine
UPF1 copurifies with polymerase d and ectopically ex-
pressed human UPF1 coimmunoprecipitated with theseparated by SDS-PAGE, transferred to nitrocellulose filters, and subjected to autoradiography. Protein amounts were controlled by probing the
same filters with anti-UPF1 and anti-ATR antibodies. The lower band in the upper panel may represent an ATR substrate coimmunoprecipitating
with ATR proteins.
(G) HeLa cells were transfected with shRNA against ATR and empty-vector controls. Five days after transfection, total proteins were prepared
and immunoprecipitation and western-blot experiments were performed as in (E) Numbers indicate the mean ratio of anti-phospho-S/T-Q signal
relative to the anti-UPF1 signal, after normalization to the empty-vector sample.
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438Figure 4. UPF1 Interacts with DNA Polymerase d
HeLa cells were treated with 2 mM hydroxyurea for 24 hr and then released into S phase for 2 hr or left asynchronous. Total-cell extracts were
prepared, and endogenous UPF1 (left), p125 catalytic subunit of pol d (middle), and UPF2 (right) were immunoprecipitated with specific anti-
bodies. Immunoprecipitates were resolved by SDS-PAGE and analyzed by western blotting with the antibodies indicated on the right. IgGs
were used as control for immunoprecipitation specificity. The unrelated a-Tubulin is not detected in the UPF1 immunoprecipitates. The asterisk
indicates a band of unknown nature reactive to UPF1 antibodies.endogenous p66 subunit of pol d in HeLa cell extracts
[26]. To corroborate this interaction, we prepared total-
protein extracts from HeLa cells that were unsynchro-
nized or synchronized in S phase. Reciprocal coimmu-
noprecipitation of UPF1 and the catalytic subunit of
pol d (p125) was observed, and this interaction was en-
hanced in S phase (Figure 4). Physical association of
UPF1 was also observed with the NMD factor UPF2,
whereas no interaction was detected between UPF2 and
p125 (Figure 4). Thus, UPF1 seems to assemble into dis-
tinguishable complexes to perform functions in NMD
(with UPF2) and DNA synthesis (with pol d). It is conceiv-
able that UPF1 DNA helicase activity assists pol d to
facilitate fork progression or DNA repair. In addition,
UPF1 may participate in S phase progression and DNA
repair through regulation of specific mRNAs. Kaygun
and Marzluff have recently demonstrated that both
UPF1 and ATR are required for the regulated degrada-
tion of replication-dependent histone mRNAs when cells
exit S phase and after hydroxyurea treatment [27]. It is
possible that in response to DNA damage and during
replication, ATR-mediated phosphorylation and chro-
matin loading of UPF1 are important for the degradation
of these mRNAs.
In conclusion, our results demonstrate for the first
time that UPF1 is essential for human cells to progress
through S phase, protecting against genome instability.
We suspect that the cell lethality induced by UPF1 de-
pletion as well as the embryonic death observed in
UPF1-KO mice [28] may derive (at least in part) from a
failure in DNA replication. The fact that yeast and worm
UPF1 mutants are viable, even though the degradation
of PTC-containing mRNAs is extinguished [29–31],
could indicate that the essential role for UPF1 in DNA
replication and genome stability is an evolutionarily late
acquisition. However, further studies that assess DNA
replication in yeast and worm UPF1 mutants are re-
quired to elucidate this point.
Our study, together with other recently published data
[9–11, 27], points to unexpected new roles for NMD fac-
tors in DNA replication, DNA repair, and telomere integ-
rity. Thus, these components seem to sit at the cross-
roads between DNA and RNA surveillance networks,
and they may function in a complex to coordinate theglobal cellular response to replicative and genotoxic
stresses. It will be fascinating to discover whether these
multiple roles are genetically separable.
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